Article & News

Gubba Group
Virupaksha Organics gets SEBI nod for ₹740 crore IPO

Virupaksha Organics Limited, a pharmaceutical company engaged in the manufacture of active pharmaceutical ingredients (APIs) and intermediates, has received the Securities and Exchange Board of

Gubba Group
Pharma benefits in EU-India Free Trade Agreement

Conclusion of ‘landmark’ deal significantly enhances trade, investment and supply chains, notably granting beneficial tariff reductions for the pharma industry.The agreement will further integrate Europe